What actually happens when you miss a tirzepatide dose

Tirzepatide stays active in the body for roughly a week after each injection, so a single missed dose rarely wipes out progress — the four-day rule accounts for this.
Never double up: taking two doses close together significantly raises the risk of nausea, vomiting and other gastrointestinal side effects.
Your injection day can be shifted by up to three days if needed (useful for travel or scheduling) as long as the gap between any two doses is at least four days.
If you've missed more than one injection in a row, speak to your prescriber before resuming, particularly if you're considering moving back up to a higher dose.

If you've missed a tirzepatide dose, the answer is simpler than most people fear: take it as soon as you remember, provided at least four days remain before your next scheduled injection. If fewer than four days remain, skip it and carry on with your usual day. Tirzepatide (Mounjaro) is a prescription-only medicine, and any uncertainty about your dosing schedule is best resolved with the prescriber who knows your full clinical picture — but the rule above reflects what the SmPC advises, and it's worth understanding why.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The dose-miss rules that patients get wrong, and the ones that actually matter

The myth: missing one dose means starting over

A question our prescribers hear most weeks is some version of this: "I missed my injection on Monday, have I ruined everything?" The short answer is no. Tirzepatide has a long half-life; the medicine you injected the week before is still doing meaningful work even several days later. One missed dose does not reset your body's response or undo recent weight changes.

Where people go wrong is in trying to compensate. Taking a catch-up dose on top of a regular one is the main source of preventable side effects in this medicine. The nausea that many people experience in the early weeks of treatment is dose-related, so doubling up is essentially volunteering for the worst of it. The Patient Information Leaflet for tirzepatide dosing is explicit: if you realise you've missed an injection more than four days after it was due, skip it entirely.

The four-day window is the hinge the whole rule turns on. Within four days of the missed dose, take it and then return to your usual schedule. Beyond four days, leave it and wait. Our Mounjaro missed dose guide covers exactly what to do in both scenarios, so it's worth a read before you make any changes to your injection timing.

What changes if you've missed several weeks

Missing one or even two injections is a different situation from going without tirzepatide for several weeks. A longer gap matters for two reasons. First, appetite and blood-sugar regulation may have shifted back toward baseline, which means the dose that felt manageable before could feel more intense when restarted. Second, if you had titrated up to a higher strength, resuming at that level after a sustained break carries a higher risk of side effects than it did when you first reached it.

This is covered in more detail for people who've missed a full week of Mounjaro or longer. The practical implication is that your prescriber may want to consider whether you should step back to a lower dose before continuing, rather than picking up where you left off. That decision belongs with the clinician, not a general guide.

The one-week gap scenario is common enough that it's worth reading about specifically if that's where you are. The NHS medicines page for tirzepatide also covers missed doses in plain language and is a reliable reference to bookmark.

Rescheduling injections without losing your rhythm

Life doesn't always cooperate with a fixed weekly injection day. The good news is that tirzepatide allows some flexibility. You can move your injection day by up to three days in either direction (earlier or later) as long as at least four days separate any two consecutive doses. So if your usual day is Monday and you need to travel Thursday through Sunday, shifting to Thursday for one week is fine, provided your previous injection was at least four days earlier.

This flexibility is genuinely useful but has a limit. It's a short-term adjustment, not a reason to treat the schedule loosely. Consistency matters for how steadily the medicine works and for managing side effects. Once you've navigated the disruption, returning to a fixed day each week is the most straightforward approach.

For those deciding between available strengths and how titration fits into their schedule, the Mounjaro 5mg guide explains what a typical dose progression looks like in practice. Understanding the schedule before a disruption makes it easier to manage when one happens.

When to contact your prescriber, not just read the leaflet

Most single missed doses are handled cleanly by the four-day rule, with no clinical involvement needed. But some situations do warrant a conversation. If you've missed multiple injections because of illness, surgery or a significant change in how you're tolerating the medicine, your prescriber needs to know before you continue, especially if you were on a higher dose and experienced significant gastrointestinal symptoms before the gap.

Similarly, if you've been managing side effects by informally reducing your dose (for example, skipping a week yourself when nausea was bad), that pattern is worth discussing openly. The FAQs on the nume, sorry, on the FAQ page cover common practical questions, and the clinical team is reachable seven days a week for aftercare queries. You can also report any unexpected or persistent side effects, including those that arise after a dose change, via the MHRA's Yellow Card scheme, it exists precisely so that real-world experiences with medicines like tirzepatide continue to be monitored.

If you're not yet on tirzepatide and are thinking through how the schedule would work for you, a free consultation through our treatment page is where to start. A prescriber will review your full picture the same day (a real clinician, not software) and can talk through what the weekly routine actually looks like.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions